Stephen Rocamboli
Director/Board Member at ESPERION THERAPEUTICS, INC.
Net worth: 76 551 $ as of 30/04/2024
Network origin in Stephen Rocamboli first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 | |
| Public Company | Pharmaceuticals: Major | 18 | |
| Public Company | Pharmaceuticals: Other | 16 | |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States.
13
| Private Company | Investment Managers | 13 |
| Public Company | Biotechnology | 8 | |
Chitina Sciences, Inc.
 Chitina Sciences, Inc. Financial ConglomeratesFinance Chitina Sciences, Inc. operates as a development stage company. The company is headquartered in New York, NY.
2
| Private Company | Financial Conglomerates | 2 |
Orion Biomedical Fund LP
1
| Subsidiary | 1 | |
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york.
1
| Subsidiary | Investment Managers | 1 |
Cortice Biosciences, Inc.
 Cortice Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Cortice Biosciences, Inc. manufactures pharmaceutical products. The company is headquartered in New York.
1
| Private Company | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Stephen Rocamboli via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
 Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Biotechnology | President Director of Finance/CFO | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| VIVUS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Executive Officer | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Investment Managers | Founder Founder Corporate Officer/Principal Private Equity Investor | |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
| CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Biotechnology | Director/Board Member Chairman | |
Cordova Sciences, Inc.
 Cordova Sciences, Inc. Financial ConglomeratesFinance Cordova Sciences, Inc. operates as a blank check company. It is a development stage company and serves as a vehicle to effect a merger, exchange of capital stock, and asset acquisition. The company was founded on August 12, 2005 and is headquartered in New York, NY. | Financial Conglomerates | President Corporate Secretary Corporate Officer/Principal | |
Seward Sciences, Inc.
 Seward Sciences, Inc. Financial ConglomeratesFinance Seward Sciences, Inc. operates as a development stage company. The company is headquartered in New York, NY. | Financial Conglomerates | Chief Executive Officer President Corporate Officer/Principal | |
Sitka Sciences, Inc.
 Sitka Sciences, Inc. Financial ConglomeratesFinance Sitka Sciences, Inc. operates as a development stage company. It intends to acquire or merge with an operating company. The company was founded on August 12, 2005 and is headquartered in Wilmington, DE. | Financial Conglomerates | President Chief Executive Officer Corporate Officer/Principal | |
Riverbank Capital Securities, Inc.
 Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The company is based in New York, NY. | Investment Banks/Brokers | Director/Board Member Director/Board Member Corporate Officer/Principal Chairman | |
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Sales & Marketing | |
| CORMEDIX INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| FORTRESS BIOTECH, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Public Communications Contact | |
Lung Therapeutics, Inc.
 Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Doctorate Degree | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree Undergraduate Degree | |
PolaRx Biopharmaceuticals
 PolaRx Biopharmaceuticals Miscellaneous Commercial ServicesCommercial Services Part of Swedish Orphan Biovitrum AB, PolaRx Biopharmaceuticals is a company that manufactures TriOxide drugs for the treatment of leukemia and other cancers. The company is based in New York, NY. The company was founded by Fred H. Mermelstein, Peter Morgan Kash, Raymond P. Warrell. PolaRx Biopharmaceuticals was acquired by CTI BioPharma Corp., part of Swedish Orphan Biovitrum AB from June 27, 2023 on January 13, 2000 for $17.50 million. | Miscellaneous Commercial Services | Founder Founder | |
| University of Utah | College/University | Doctorate Degree Doctorate Degree | |
| City University of New York | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY. | College/University | Graduate Degree Undergraduate Degree | |
| The University of Texas at Austin | College/University | Doctorate Degree Undergraduate Degree | |
| Yale University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Rider University | College/University | Undergraduate Degree Graduate Degree | |
| Yeshiva University | College/University | Doctorate Degree Undergraduate Degree | |
Javelin Pharmaceuticals, Inc.
 Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Founder | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder Founder Director of Finance/CFO Founder Chief Executive Officer | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal Doctorate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| CAPRICOR THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Secretary Director/Board Member Director/Board Member | |
| DURATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistics
International
| United States | 50 |
| Denmark | 2 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 15 |
| Finance | 8 |
| Commercial Services | 2 |
| Technology Services | 2 |
Operational
| Director/Board Member | 356 |
| Corporate Officer/Principal | 188 |
| President | 99 |
| Independent Dir/Board Member | 98 |
| Chief Executive Officer | 68 |
Most connected contacts
| Insiders | |
|---|---|
| Joshua Kazam | 43 |
| Peter Morgan Kash | 32 |
| Jay Shepard | 30 |
| Edward Benz | 29 |
| Nicole Vitullo | 29 |
| Randy Thurman | 28 |
| J. Lobell | 27 |
| Michael Weiser | 26 |
| Yiu Nam Lau | 26 |
| Paul Manning | 26 |
| Jeffrey Berkowitz | 26 |
| David Tanen | 25 |
| Antonio Gotto | 23 |
| Shaan Gandhi | 22 |
| Harlan Weisman | 20 |
- Stock Market
- Insiders
- Stephen Rocamboli
- Company connections
